Protalix Biotherapeutics Inc., a pharmaceutical company, said Tuesday its chairman of the board is resigning to recover from an illness.
Drug and medical products company Abbott Laboratories said Tuesday it will buy Facet Biotech Corp. for about $450 million in cash, expanding the company's access to biotechnology drugs, including a potential treatment for multiple sclerosis.
Comment Wall (6 comments)
You need to be a member of SciBog: Science & Medical Writing Blogs to add comments!
Join SciBog: Science & Medical Writing Blogs
Hi,
www.genetoday.com is a networking site for biomedical science professionals.
Here one can meet other professionals in the same field, can upload pics/videos, create ones own blogs,forums,meetups,seminars and conferences.
In addittion it provides links to interesting educational websites, daily updated news in the field of biomedical science, and links to protocols.
You are invited to join www.genetoday.com
Gene Today Team
I am looking forward to your participation on this network. Will you be planning on using this space for hosting your blog?
it was very good to know about the recent applications of microarray.
At present, Unicersity of Ulster,UK,postgraduate student.
I am biotechnologist and pursuing Masters in the field. I aim to become a molecular biosciences researcher. My research interests are in Proteomics: natural peptides and venomic peptides discovery and targeting them for anticancerous therapy. Second research interests : DNA and RNA architectural studies as in structural biology. quadruplexes is the topic which i am dealing for thesis.
My third research interest is genetics and molecular biology of genes: transcriptional regulation, ribosome-polypeptide interactions.
It would be very nice we can share our research areas over the blog.
Thanks
Anup